Antineoplaston bibliography
Antineoplaston bibliography
Results of a Web of Science search for "antineoplaston*". All results have Stanislaw Burzynski as an author. Judging by article length many recent references appear to be abstracts.
Observer story, Nov 29 Guardian, On the Observer's response
1.Title: TARGETING MICRORNAS IN GLIOMA CELLS WITH ANTINEOPLASTONS
Author(s): Patil Sonali; Burzynski Stanislaw R.; Mrowczynski Emilia; et al.
Source: NEURO-ONCOLOGY Volume: 12 Supplement: 4 Pages: 10-10 Published: NOV 2010
Times Cited: 0 (from Web of Science)

2.Title: PRELIMINARY RESULTS OF A PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 (ANP) IN ADULT PATIENTS WITH RECURRENT MIXED GLIOMAS
Author(s): Burzynski Stanislaw R.; Weaver Robert A.; Janicki Tomasz J.; et al.
Source: NEURO-ONCOLOGY Volume: 12 Supplement: 4 Pages: 72-72 Published: NOV 2010 Times Cited: 0 (from Web of Science)

3. Title: ANTINEOPLASTONS INITIATE CASPASE INDUCED APOPTOSIS BY SUPPRESSING SURVIVIN EXPRESSION IN U87 GLIOBLASTOMA CELLS
Author(s): Patil S.; Burzynski S. R.; Mrowczynski E.; et al.
Source: NEURO-ONCOLOGY Volume: 12 Issue: 6 Pages: II87-II87 Published: JUN 2010
Times Cited: 0 (from Web of Science)

4. Title: A PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 INJECTIONS IN CHILDREN WITH LOW-GRADE A STROCYTOMAS
Author(s): Burzynski S. R.; Weaver R. A.; Janicki T.; et al.
Source: NEURO-ONCOLOGY Volume: 12 Issue: 6 Pages: II95-II95 Published: JUN 2010
Times Cited: 0 (from Web of Science)

5. Title: OVER A 10-YEAR SURVIVAL AND COMPLETE RESPONSE OF A PATIENT WITH DIFFUSE INTRINSIC BRAINSTEM GLIOMA (DBSG) TREATED WITH ANTINEOPLASTONS (ANP)
Author(s): Weaver Robert A.; Szymkowski Barbara; Burzynski Stanislaw R.
Source: NEURO-ONCOLOGY Volume: 11 Issue: 6 Pages: 923-923 Published: DEC 2009
Times Cited: 0 (from Web of Science)

6. Title: PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN PATIENTS WITH BRAINSTEM GLIOMA: PROTOCOL BC-BT-11
Author(s): Burzynski Stanislaw R.; Janicki Tomasz J.; Weaver Robert A.; et al.
Source: NEURO-ONCOLOGY Volume: 11 Issue: 6 Pages: 951-951 Published: DEC 2009
Times Cited: 0 (from Web of Science)

7. Title: ANTINEOPLASTONS INHIBIT MCM COMPLEX IN GLIOBLASTOMA CELLS
Author(s): Patil Sonali; Burzynski Stanislaw R.; Chittur Sridhar; et al.
Source: NEURO-ONCOLOGY Volume: 11 Issue: 6 Pages: 957-958 Published: DEC 2009
Times Cited: 0 (from Web of Science)

8.Title: PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 INFUSIONS (ANP) IN PATIENTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA
Author(s): Burzynski S. R.; Weaver R.; Janicki T.; et al.
Source: NEURO-ONCOLOGY Volume: 10 Issue: 6 Pages: 1067-1067 Published: DEC 2008
Times Cited: 0 (from Web of Science)

9. Title: THE INGREDIENTS OF ANTINEOPLASTON AS2-1 DOWN-REGULATE GLYCOLYSIS PATHWAYS IN GLIOBLASTOMA CELLS
Author(s): Patil S.; Burzynski S.; Chittur S.; et al.
Source: NEURO-ONCOLOGY Volume: 10 Issue: 6 Pages: 1148-1148 Published: DEC 2008
Times Cited: 0 (from Web of Science)

10. Title: PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 (ANP) IN PATIENTS WITH NEWLY DIAGNOSED ANAPLASTIC ASTROCYTOMA: A PRELIMINARY REPORT
Author(s): Burzynski Stanislaw; Weaver Robert; Janicki Tomasz; et al.
Source: NEURO-ONCOLOGY Volume: 10 Issue: 5 Pages: 821-821 Published: OCT 2008
Times Cited: 0 (from Web of Science)

11. Title: Phase II study of antineoplastons A10 and AS2-1 (ANP) in children with optic pathway glioma: A preliminary report
Author(s): Burzynski Stanislaw; Weaver Robert; Janicki Tomasz; et al.
Source: NEURO-ONCOLOGY Volume: 10 Issue: 3 Pages: 450-450 Published: JUN 2008
Times Cited: 0 (from Web of Science)

12. Title: Phase II studies of antineoplastons A10 and AS2-1 (ANP) in children with newly diagnosed diffuse, intrinsic brainstem gliomas
Author(s): Burzynski S. R.; Weaver R. A.; Janicki T. J.; et al.
Source: NEURO-ONCOLOGY Volume: 9 Issue: 2 Pages: 206-206 Published: APR 2007
Times Cited: 0 (from Web of Science)

13. Title: Phase II studies of antineoplastons A10 and AS2-1 (ANP) in adult patients with diffuse, intrinsic brainstem gliomas
Author(s): Burzynski S. R.; Weaver R. A.; Janicki T. J.; et al.
Source: NEURO-ONCOLOGY Volume: 8 Issue: 4 Pages: 346-346 Published: OCT 2006
Times Cited: 0 (from Web of Science)

14. Title: Complete response of a diffuse intrinsic brainstem tumor and von hippel lindau (VHL) disease to antineoplastons A10 and AS2-1 (ANP): A case report
Author(s): Burzynski S. R.; Weaver R. A.; Szymkowski B.; et al.
Source: NEURO-ONCOLOGY Volume: 8 Issue: 4 Pages: 439-439 Published: OCT 2006
Times Cited: 0 (from Web of Science)

15. Title: Treatment of multicentric brainstem gliomas with antineoplastons (ANP) A10 and AS2-
Author(s): Burzynski S. R.; Janicki T. J.; Weaver R. A.; et al.
Source: NEURO-ONCOLOGY Volume: 8 Issue: 4 Pages: 466-466 Published: OCT 2006
Times Cited: 0 (from Web of Science)

16. Title: Targeted therapy with antineoplastons A10 and AS2-1 of high-grade, recurrent, and progressive brainstem glioma
Author(s): Burzynski SR; Janicki TJ; Weaver RA; et al.
Source: INTEGRATIVE CANCER THERAPIES Volume: 5 Issue: 1 Pages: 40-47 DOI: 10.1177/1534735405285380 Published: MAR 2006
Times Cited: 2 (from Web of Science)

17. Title: Aging: gene silencing or gene activation?
Author(s): Burzynski SR
Source: MEDICAL HYPOTHESES Volume: 64 Issue: 1 Pages: 201-208 DOI: 10.1016/j.mehy.2004.06.010 Published: 2005
Times Cited: 22 (from Web of Science)

18. Title: Phase II study of antineoplastons A10 and AS2-1 (ANP) in recurrent glioblastoma multiforme
Author(s): Weaver RA; Burzynski SR; Bestak M; et al.
Source: NEURO-ONCOLOGY Volume: 6 Issue: 4 Pages: 384-385 Published: OCT 2004
Times Cited: 0 (from Web of Science)

19. Title: Long-term survivals in phase II studies of antineoplastons A10 and AS2-1 (ANP) in patients with diffuse intrinsic brain stem glioma
Author(s): Burzynski SR; Weaver RA; Bestak M; et al.
Source: NEURO-ONCOLOGY Volume: 6 Issue: 4 Pages: 386-386 Published: OCT 2004
Times Cited: 1 (from Web of Science)

20. Title: Phase II studies of antineoplastons A10 and AS2-1 (ANP) in children with atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system. A preliminary report
Author(s): Burzynski SR; Weaver RA; Bestak M; et al.
Source: NEURO-ONCOLOGY Volume: 6 Issue: 4 Pages: 427-427 Published: OCT 2004
Times Cited: 0 (from Web of Science)

21. Title: Treatment of primitive neuroectodermal tumors (PNET) with antineoplastons A10 and AS2-1 (ANP). Peliminary results of phase II studies
Author(s): Burzynski SR; Weaver RA; Bestak M; et al.
Source: NEURO-ONCOLOGY Volume: 6 Issue: 4 Pages: 428-428 Published: OCT 2004
Times Cited: 0 (from Web of Science)

22. Title: Gene silencing - a new theory of aging
Author(s): Burzynski SR
Source: MEDICAL HYPOTHESES Volume: 60 Issue: 4 Pages: 578-583 DOI: 10.1016/S0306-9877(03)00050-1 Published: APR 2003
Times Cited: 13 (from Web of Science)

23. Title: A retrospective study of antineoplastons A10 and AS2-1 in primary brain tumours Author(s): Burzynski SR; Conde AB; Peters A; et al.
Source: CLINICAL DRUG INVESTIGATION Volume: 18 Issue: 1 Pages: 1-10 DOI: 10.2165/00044011-199918010-00001 Published: JUL 1999
Times Cited: 2 (from Web of Science) 24. Title: Efficacy of antineoplastons A10 and AS2-1
Author(s): Burzynski SR
Source: MAYO CLINIC PROCEEDINGS Volume: 74 Issue: 6 Pages: 641-641 Published: JUN 1999
Times Cited: 2 (from Web of Science)

25. Title: POTENTIAL OF ANTINEOPLASTONS IN DISEASES OF OLD-AGE
Author(s): BURZYNSKI SR
Source: DRUGS & AGING Volume: 7 Issue: 3 Pages: 157-167 DOI: 10.2165/00002512-199507030-00001 Published: SEP 1995
Times Cited: 6 (from Web of Science)

26. Title: CELLULAR ACCUMULATION OF ANTINEOPLASTON AS21 IN HUMAN HEPATOMA-CELLS
Author(s): SOLTYSIAKPAWLUCZUK D; BURZYNSKI SR
Source: CANCER LETTERS Volume: 88 Issue: 1 Pages: 107-112 DOI: 10.1016/0304-3835(94)03621-O Published: JAN 6 1995
Times Cited: 3 (from Web of Science)

27. Title: THE INFLUENCE OF ANTINEOPLASTON A5 ON PARTICULAR SUBTYPES OF CENTRAL DOPAMINERGIC RECEPTORS
Author(s): JUSZKIEWICZ M; CHODKOWSKA A; BURZYNSKI SR; et al.
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 21 Issue: 4 Pages: 153-156 Published: 1995
Times Cited: 1 (from Web of Science)

28. Title: THE INFLUENCE OF ANTINEOPLASTON A5 ON THE CENTRAL DOPAMINERGIC STRUCTURES
Author(s): JUSZKIEWICZ M; CHODKOWSKA A; BURZYNSKI SR; et al.
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 20 Issue: 4 Pages: 161-167 Published: 1994
Times Cited: 3 (from Web of Science)

29. Title: ANTINEOPLASTONS - THE CONTROVERSY CONTINUES
Author(s): BURZYNSKI S
Source: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION Volume: 269 Issue: 4 Pages: 475-475 Published: JAN 27 1993
Times Cited: 2 (from Web of Science)

30. Title: TREATMENT OF HORMONALLY REFRACTORY CANCER OF THE PROSTATE WITH ANTINEOPLASTON AS2-1
Author(s): BURZYNSKI SR; KUBOVE E; BURZYNSKI B
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 16 Issue: 7 Pages: 361-369 Published: 1990
Times Cited: 8 (from Web of Science)

31. Title: INITIAL CLINICAL-STUDY WITH ANTINEOPLASTON-A2 INJECTIONS IN CANCER-PATIENTS WITH 5 YEARS FOLLOW-UP
Author(s): BURZYNSKI SR; KUBOVE E
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 13 Supplement: 1 Pages: 1-11 Published: 1987
Times Cited: 8 (from Web of Science)

32. Title: INVITRO CANCER GROWTH-INHIBITION AND ANIMAL TOXICITY STUDIES OF ANTINEOPLASTON-A3
Author(s): LEE SS; MOHABBAT MO; BURZYNSKI SR
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 13 Supplement: 1 Pages: 13-16 Published: 1987
Times Cited: 2 (from Web of Science)

33. Title: PHASE-1 CLINICAL-STUDIES OF ANTINEOPLASTON-A3 INJECTIONS
Author(s): BURZYNSKI SR; KUBOVE E
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 13 Supplement: 1 Pages: 17-29 Published: 1987
Times Cited: 4 (from Web of Science)

34. Title: TISSUE-CULTURE AND ANIMAL TOXICITY STUDIES OF ANTINEOPLASTON-A5
Author(s): LEE SS; BURZYNSKI SR
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 13 Supplement: 1 Pages: 31-35 Published: 1987
Times Cited: 2 (from Web of Science)

35. Title: PHASE-1 CLINICAL-STUDIES OF ANTINEOPLASTON-A5 INJECTIONS
Author(s): BURZYNSKI SR; KUBOVE E; BURZYNSKI B
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 13 Supplement: 1 Pages: 37-43 Published: 1987
Times Cited: 5 (from Web of Science)

36. Title: PHARMACOKINETIC STUDY OF RADIOACTIVE ANTINEOPLASTON-A10 FOLLOWING ORAL-ADMINISTRATION IN RATS
Author(s): ASHRAF AQ; LIAU MC; KAMPALATH BN; et al.
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 13 Supplement: 1 Pages: 45-50 Published: 1987
Times Cited: 3 (from Web of Science)

37. Title: CHEMOPREVENTION BY ANTINEOPLASTON-A10 OF BENZO(A)PYRENE-INDUCED PULMONARY NEOPLASIA
Author(s): KAMPALATH BN; LIAU MC; BURZYNSKI B; et al.
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 13 Supplement: 1 Pages: 51-55 Published: 1987
Times Cited: 6 (from Web of Science)

38. Title: QUANTITATIVE ASSAY OF PLASMA AND URINARY PEPTIDES AS AN AID FOR THE EVALUATION OF CANCER-PATIENTS UNDERGOING ANTINEOPLASTON THERAPY
Author(s): LIAU MC; SZOPA M; BURZYNSKI B; et al.
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 13 Supplement: 1 Pages: 61-70 Published: 1987
Times Cited: 5 (from Web of Science)

39. Title: STEREOCHEMICAL MODELING STUDIES OF THE INTERACTION OF ANTINEOPLASTON-A10 WITH DNA
Author(s): HENDRY LB; MULDOON TG; BURZYNSKI SR; et al.
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 13 Supplement: 1 Pages: 77-81 Published: 1987
Times Cited: 12 (from Web of Science)

40. Title: ANTINEOPLASTONS - HISTORY OF THE RESEARCH .1.
Author(s): BURZYNSKI SR
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 12 Supplement: 1 Pages: 1-9 Published: 1986
Times Cited: 29 (from Web of Science)

41. Title: PRECLINICAL STUDIES ON ANTINEOPLASTON-AS2-1 AND ANTINEOPLASTON-AS2-5
Author(s): BURZYNSKI SR; MOHABBAT MO; LEE SS
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 12 Supplement: 1 Pages: 11-16 Published: 1986
Times Cited: 10 (from Web of Science)

42. Title: TOXICOLOGY STUDIES ON ANTINEOPLASTON-AS2-5 INJECTIONS IN CANCER-PATIENTS
Author(s): BURZYNSKI SR
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 12 Supplement: 1 Pages: 17-24 Published: 1986
Times Cited: 2 (from Web of Science)

43. Title: TOXICOLOGY STUDIES ON ANTINEOPLASTON-AS2-1 INJECTIONS IN CANCER-PATIENTS
Author(s): BURZYNSKI SR; BURZYNSKI B; MOHABBAT MO
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 12 Supplement: 1 Pages: 25-35 Published: 1986
Times Cited: 5 (from Web of Science)

44. Title: PRECLINICAL STUDIES ON ANTINEOPLASTON-A10 INJECTIONS
Author(s): ASHRAF AQ; LIAU MC; MOHABBAT MO; et al.
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 12 Supplement: 1 Pages: 37-45 Published: 1986
Times Cited: 14 (from Web of Science)

45. Title: TOXICOLOGY STUDIES ON ANTINEOPLASTON-A10 INJECTIONS IN CANCER-PATIENTS
Author(s): BURZYNSKI SR; KUBOVE E
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 12 Supplement: 1 Pages: 47-55 Published: 1986
Times Cited: 3 (from Web of Science)

46. Title: CHRONIC ANIMAL TOXICITY STUDIES ON ANTINEOPLASTON-A2
Author(s): BURZYNSKI SR; MOHABBAT MO
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 12 Supplement: 1 Pages: 73-75 Published: 1986
Times Cited: 2 (from Web of Science)

47. Title: AN UNIQUE PATTERN OF GROWTH-INHIBITION BY ANTINEOPLASTON-A5 ON A T-LEUKEMIA CELL-LINE
Author(s): LEE SS; BURZYNSKI SR
Source: TUMOUR BIOLOGY Volume: 7 Issue: 4 Pages: 295-295 Published: 1986
Times Cited: 0 (from Web of Science)

48. Title: QUANTITATIVE ASSAY OF PLASMA AND URINARY PEPTIDES AS AN AID FOR THE EVALUATION OF CANCER-PATIENTS UNDERGOING ANTINEOPLASTON THERAPY
Author(s): LIAU MC; SZOPA M; BURZYNSKI B; et al.
Source: TUMOUR BIOLOGY Volume: 6 Issue: 4 Pages: 430-430 Published: 1985
Times Cited: 0 (from Web of Science)

49. Title: TOXICOLOGY STUDIES ON ORAL FORMULATION OF ANTINEOPLASTON-A10 IN CANCER-PATIENTS
Author(s): BURZYNSKI SR; MOHABBAT MO; BURZYNSKI B
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 10 Issue: 8-9 Pages: 611-619 Published: 1984
Times Cited: 21 (from Web of Science)

50. Title: ANIMAL TOXICOLOGY STUDIES ON ORAL FORMULATION OF ANTINEOPLASTON-A10
Author(s): BURZYNSKI SR; MOHABBAT MO; BURZYNSKI B
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 10 Issue: 2 Pages: 113-118 Published: 1984
Times Cited: 17 (from Web of Science)

51. Title: TISSUE-CULTURE AND ACUTE ANIMAL TOXICITY STUDIES OF ANTINEOPLASTON-A2
Author(s): LEE SS; MOHABBAT MO; BURZYNSKI SR
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 10 Issue: 8-9 Pages: 607-610 Published: 1984
Times Cited: 8 (from Web of Science)

52. Title: HUMAN TOXICOLOGY STUDIES ON ORAL FORMULATION OF ANTINEOPLASTON-A10
Author(s): BURZYNSKI SR; MOHABBAT MO; BURZYNSKI B
Source: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH Volume: 10 Issue: 12 Pages: 891-909 Published: 1984
Times Cited: 19 (from Web of Science)

53. Title: ANTINEOPLASTON-A IN CANCER-THERAPY .1.
Author(s): BURZYNSKI SR; STOLZMANN Z; SZOPA B; et al.
Source: PHYSIOLOGICAL CHEMISTRY AND PHYSICS Volume: 9 Issue: 6 Pages: 485-500 Published: 1977
Times Cited: 17 (from Web of Science)

54. Title: ANTINEOPLASTONS - BIOCHEMICAL DEFENSE AGAINST CANCER
Author(s): BURZYNSKI SR
Source: PHYSIOLOGICAL CHEMISTRY AND PHYSICS Volume: 8 Issue: 3 Pages: 275-279 Published: 1976
Times Cited: 37 (from Web of Science)